AU511080B2 - Prolonged release pharmaceutical preparations - Google Patents

Prolonged release pharmaceutical preparations

Info

Publication number
AU511080B2
AU511080B2 AU30986/77A AU3098677A AU511080B2 AU 511080 B2 AU511080 B2 AU 511080B2 AU 30986/77 A AU30986/77 A AU 30986/77A AU 3098677 A AU3098677 A AU 3098677A AU 511080 B2 AU511080 B2 AU 511080B2
Authority
AU
Australia
Prior art keywords
pharmaceutical preparations
release pharmaceutical
prolonged release
prolonged
preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU30986/77A
Other versions
AU3098677A (en
Inventor
Y Raghunandan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Corp
Original Assignee
Pennwalt Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennwalt Corp filed Critical Pennwalt Corp
Publication of AU3098677A publication Critical patent/AU3098677A/en
Application granted granted Critical
Publication of AU511080B2 publication Critical patent/AU511080B2/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU30986/77A 1976-11-26 1977-11-25 Prolonged release pharmaceutical preparations Expired AU511080B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US74532576A 1976-11-26 1976-11-26
USUS745325 1976-11-26
US80010577A 1977-05-24 1977-05-24
USUS800105 1977-05-24

Publications (2)

Publication Number Publication Date
AU3098677A AU3098677A (en) 1979-05-31
AU511080B2 true AU511080B2 (en) 1980-07-24

Family

ID=27114439

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30986/77A Expired AU511080B2 (en) 1976-11-26 1977-11-25 Prolonged release pharmaceutical preparations

Country Status (21)

Country Link
JP (1) JPS609697B2 (en)
AR (1) AR218047A1 (en)
AT (1) AT359197B (en)
AU (1) AU511080B2 (en)
BE (1) BE861141A (en)
CA (1) CA1086226A (en)
CH (1) CH639560A5 (en)
DE (1) DE2752728C2 (en)
DK (1) DK150534C (en)
FI (1) FI65910C (en)
FR (1) FR2373288A1 (en)
GB (1) GB1544761A (en)
GR (1) GR61724B (en)
IE (1) IE45998B1 (en)
IL (1) IL53462A (en)
LU (1) LU78584A1 (en)
NL (1) NL182283C (en)
NO (1) NO147626C (en)
NZ (1) NZ185772A (en)
PT (1) PT67323B (en)
SE (1) SE426781B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2929456A1 (en) 1979-07-20 1981-02-05 Lentia Gmbh COMPOSITION WITH EXTENDED BRONCHOLYTIC AND TOCOLYTIC EFFECTIVENESS, A METHOD FOR THE PRODUCTION THEREOF AND BRONCHOLYTIC AND TOKOLYTICALLY ACTIVE AGENT
CA1236023A (en) * 1984-07-18 1988-05-03 Yegnaswami Raghunathan Controlled release pharmaceutical preparations
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US5188825A (en) * 1989-12-28 1993-02-23 Iles Martin C Freeze-dried dosage forms and methods for preparing the same
ES2067957T3 (en) * 1990-08-07 1995-04-01 Pfizer USE OF INTERFACE POLYMERIZED MEMBRANES IN RELEASE DEVICES.
US5436011A (en) * 1993-04-16 1995-07-25 Bristol-Myers Squibb Company Solid pharmaceutical dosage form and a method for reducing abrasion
US20130230587A1 (en) * 2010-11-10 2013-09-05 Rubicon Research Private Limited Sustained release compositions
FR3059903B1 (en) * 2016-12-08 2019-03-22 Salsarulo Pharma ORAL MEDICINE COMPRISING AN OSMOTIC LAXATIVE INCORPORATED IN A MATRIX BASED ON VEGETABLE FATS
IL273904B2 (en) 2017-10-09 2024-08-01 Rhodes Pharmaceuticals Lp Pharmaceutical resinate compositions and methods of making and using thereof
JP7504922B2 (en) * 2019-05-23 2024-06-24 ジー．デー ソチエタ ペル アツィオニ Filling unit for filling containers, in particular cartridges, with liquid products from the pharmaceutical industry

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE550150A (en) * 1955-08-08
GB843118A (en) * 1957-02-13 1960-08-04 Ici Ltd Pharmaceutical compositions containing piperidine derivatives
US3158538A (en) * 1961-02-23 1964-11-24 White Lab Inc Antidiarrheal compositions and method of using
GB982150A (en) * 1961-09-29 1965-02-03 Glaxo Group Ltd Therapeutic resin complexes
US3594470A (en) * 1968-02-19 1971-07-20 Abbott Lab Chewable tablets including coated particles of pseudoephedrine-weak cation exchange resin
GB1218102A (en) * 1968-03-15 1971-01-06 Philips Nv Improvements in medicaments comprising drug/ion-exchange resin compounds
CA935092A (en) * 1968-09-03 1973-10-09 S. Banker Gilbert Molecular drug entrapment process and compositions
CA927282A (en) * 1968-09-03 1973-05-29 S. Banker Gilbert Entrapment compositions and processes
DE2343218C2 (en) * 1973-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Pellets containing furosemide

Also Published As

Publication number Publication date
NL182283B (en) 1987-09-16
DK523277A (en) 1978-05-27
NO147626B (en) 1983-02-07
IE45998L (en) 1978-05-26
PT67323A (en) 1977-12-01
DK150534C (en) 1987-10-12
FR2373288B1 (en) 1980-06-13
NO147626C (en) 1983-05-25
FI65910B (en) 1984-04-30
DE2752728A1 (en) 1978-06-01
SE426781B (en) 1983-02-14
FR2373288A1 (en) 1978-07-07
LU78584A1 (en) 1978-04-20
IL53462A (en) 1980-12-31
DK150534B (en) 1987-03-23
NZ185772A (en) 1978-12-18
NO774051L (en) 1978-05-29
JPS609697B2 (en) 1985-03-12
IL53462A0 (en) 1978-01-31
CA1086226A (en) 1980-09-23
NL7712996A (en) 1978-05-30
CH639560A5 (en) 1983-11-30
DE2752728C2 (en) 1985-08-01
AT359197B (en) 1980-10-27
GB1544761A (en) 1979-04-25
SE7713370L (en) 1978-05-27
ATA848077A (en) 1980-03-15
PT67323B (en) 1979-04-24
BE861141A (en) 1978-03-16
FI773568A (en) 1978-05-27
NL182283C (en) 1988-02-16
AU3098677A (en) 1979-05-31
IE45998B1 (en) 1983-01-26
FI65910C (en) 1984-08-10
GR61724B (en) 1978-12-29
AR218047A1 (en) 1980-05-15
JPS5369822A (en) 1978-06-21

Similar Documents

Publication Publication Date Title
AU508266B2 (en) Controlled release preparations
AU515341B2 (en) Pharmaceutical composition
AU513845B2 (en) Pharmaceutical dosage forms
AU534959B2 (en) Pharmaceutical lipsome
AU505355B2 (en) Sustained release formulation
AU508421B2 (en) Tooch preparations
AU512626B2 (en) 4-Hydroxyphenylalkanolamine derivatives and preparation thereof
AU3191277A (en) Tumour-resolving medicament
AU507700B2 (en) Pharmaceutical filter
AU514848B2 (en) Biological preparations
AU511080B2 (en) Prolonged release pharmaceutical preparations
AU513829B2 (en) Modified montmorillonite pharmaceutical
AU521916B2 (en) Anti-caries preparations
AU508191B2 (en) Pharmaceutical composition
AU513901B2 (en) Oral administration for pyrethroids
AU517608B2 (en) Medicaments
ZA776645B (en) Pharmaceutical preparations
HK3283A (en) Pharmaceutical preparations for venotonic use
AU500434B2 (en) Pharmaceutical combination preparations
AU510887B2 (en) Vitamin c preparations
AU495185B2 (en) New pharmaceutical compositions
IE790683L (en) Pharmaceutical preparations
IE792309L (en) Pharmaceutical preparations
ZA785929B (en) Pharmaceutical preparations
PH15249A (en) Pharmaceutical preparations